Telix Pharmaceuticals Limited (DUS:T3X) Financings
Financings
| Raise | Date |
|---|---|
| At-the-market programme of new fully paid ordinary shares in the form of American Depository Shares (ADSs) Announced: Morgan Stanley & Co. LLC +1 Dealers: Morgan Stanley & Co. LLC, William Blair & Company, L.L.C. Use of proceeds: To facilitate greater access to the Company's securities on the Nasdaq stock exchange | Aug 20, 2026 |
| 1.50 per cent convertible notes due 2031 Made bigger: US$600M · J.P. Morgan Securities plc Dealers: J.P. Morgan Securities plc (lead) Use of proceeds: Refinancing of existing convertible bonds alongside a concurrent repurchase | Apr 15, 2026 |